Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04550429
Other study ID # STU00211845
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 21, 2020
Est. completion date September 11, 2023

Study information

Verified date February 2024
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to compare the outcomes of patients undergoing hysteroscopy with a Myosure device with a pressure of 60 mmHg to those using the standard of 80 mmHg.


Description:

An a priori sample size calculation was completed. To achieve 80% power and an alpha of .05, the study team needed a sample size of 68 total with 34 participants in each group.The study will be a double-blind randomized control trial. Patients will be recruited based on surgery type (hysteroscopy) and consented using a written consent by the research coordinator with sufficient time to ensure patient comprehension and allow for any questions. The consent process will happen in the pre-operative appointment. Participants will then be randomized to either the standard of care of 80mmHg or the experimental pressure of 60 mmHg for uterine filling pressure via an automated randomization program. The physician performing the surgery and the patient will not know what group they are assigned to. The procedure involved in the study will be hysteroscopy. Hysteroscopy is a procedure that is used to diagnose and sometimes treat intrauterine pathologies. In order to visualize the uterus, pressurized saline is used to distend the uterus. In this study, the specific hysteroscopic procedure will involve the removal of uterine fibroids with a MyoSure Hysteroscopic Morcellator device. These tissue samples will be collected and sent to Pathology to be weighed. During the surgery, the surgeon will be able to request an adjustment pressure if visualization is not adequate. Physicians will start with a pressure of 80mmHg. Once physician is ready to introduce the myosure hysteroscopy device, the pressure level will then be randomized. During the procedure, monitoring will be done by anesthesia through the use of pulse oximetry and measurement of vitals during the Monitored Anesthesia Care. There is also real-time monitoring of hysteroscopic fluid deficit via the fluid management system that is attached to the hysteroscopic pump. Fluid deficit can also be confirmed by the nurse who manually counts the amount of fluid used during theprocedure. Per policy, once a 2500mL deficit is reached, the procedure is terminated. After the surgery, the surgeon will fill out a questionnaire that measures the outcomes of surgeon satisfaction and visualization during the procedure. The other end points of procedure time, specimen weight, volume of normal saline used, any changes in pressure needed during the surgery, and whether the patient required Lasix post-operatively will also be collected at this time.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date September 11, 2023
Est. primary completion date September 11, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients electing for operative or diagnostic hysteroscopy procedures for management of polyps and fibroids - Age equal to or greater than 18 - Ability to understand and willingness to sign consent form. We will include non-English speaking patients in this study Exclusion Criteria: - Patients electing for operative and diagnostic hysteroscopy procedures with polyps and fibroids - Patients under the age of 18

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MyoSure Hysteroscopic Morcellator Device
This device is normally used for this procedure, but I included it as intervention because we will lower the pressure for one arm of the study (treatment) and keep the pressure in the other arm (control) as the standard of care.

Locations

Country Name City State
United States Center for Comprehensive Gynecology Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physician Survey to assess visualization Determining whether lowering pressure on hysteroscopic morcellator during hysteroscopy, using block randomization, affects visualization for surgeon using a post-op survey for surgeon to gauge outcomes. Through study completion, an average of 1 year
Primary Procedure Time Duration of surgery to assess if pressure changes affects length of surgery time. Through study completion, an average of 1 year
Primary Specimen Weight Specimen will be sent to pathology to note weight in grams. Through study completion, an average of 1 year
Primary Amount of Fluid Volume of normal saline used during procedure. Through study completion, an average of 1 year
Primary Lasix administered post-operatively Noting yes or no if Lasix was administered post-operatively. Through study completion, an average of 1 year
Primary Change in pressure was needed Noting if pressure needed changing by surgeon during the procedure. Through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Terminated NCT02209545 - Misoprostol for Reduction of Blood Loss During Fibroid Surgery Phase 4
Completed NCT00332033 - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Phase 2
Recruiting NCT04849858 - Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures Phase 3
Terminated NCT00001850 - Evaluation of Women With Endocrine and Reproductive-Related Conditions
Completed NCT02620748 - Use of Intravenous Tranexamic Acid During Myomectomy Phase 1
Completed NCT02954744 - High-intensity Focused Ultrasound in Treatment of Uterine Fibroid N/A
Terminated NCT00710346 - Establishment of Fibroid Tissue Bank
Withdrawn NCT02703246 - Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes N/A
Not yet recruiting NCT01347385 - Barbed Suture Versus Traditional Suture Material for Laparoscopic Myomectomy N/A
Completed NCT02620345 - Fibroids in Women of Reproductive Age and Women Pregnancy Phase 4
Completed NCT01581944 - Gonadotropin-releasing Hormone Agonist Prior to Myomectomy Phase 3
Completed NCT04071574 - Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Phase 1/Phase 2
Completed NCT02812186 - Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Phase 4
Recruiting NCT02288130 - Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy Phase 4
Withdrawn NCT01671215 - Endometrial and Myometrial Changes, With and Without Fibroids N/A
Completed NCT01936493 - Biologic Predictors of Leiomyoma Treatment Outcomes N/A
Completed NCT00995878 - The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. Phase 4